First Product. The following Development & Regulatory Milestone Payments shall be made for the First Product: [*****] [*****] [*****] [*****] [*****] [*****] [*****] [*****] [*****] [*****]
Appears in 2 contracts
Sources: 2020 Cla Amendment and Restatement Agreement (CureVac N.V.), Collaboration and License Agreement (CureVac B.V.)
First Product. The following Development & Regulatory Sales Milestone Payments shall be made for the First Product: [*****] [*****] [*****] [*****] [*****] [*****] [*****] [*****] [*****] [*****]
Appears in 2 contracts
Sources: 2020 Cla Amendment and Restatement Agreement (CureVac N.V.), Collaboration and License Agreement (CureVac B.V.)
First Product. The following Development & Regulatory Milestone Payments shall be made for the First Product: [*****] [*****] [*****] [*****] [*****] [*****] [*****] [*****] [*****] [*****]]
Appears in 1 contract
Sources: Fourth Amendment and Restatement Agreement (CureVac N.V.)
First Product. The following Development & Regulatory Sales Milestone Payments shall be made for the First Product: [*****] [*****] [*****] [*****] [*****] [*****] [*****] [*****] [*****] [*****]
Appears in 1 contract
Sources: Fourth Amendment and Restatement Agreement (CureVac N.V.)